Premium
PROSTATE‐SPECIFIC ANTIGEN VELOCITY (PSAV) RISK COUNT IMPROVES THE SPECIFICITY OF SCREENING FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
Author(s) -
Carter H. Ballentine
Publication year - 2012
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2011.10908.x
Subject(s) - prostate cancer , prostate specific antigen , medicine , citation , oncology , prostate , urology , cancer , gynecology , library science , computer science